Transglutaminase variants with improved specificity

Details for Australian Patent Application No. 2008219238 (hide)

Owner Novo Nordisk Health Care AG

Inventors Hu, Sean; Zin, Xao; Su, Jing; Jianhua, Wang; Norskov-Lauritsen, Leif; Chang, Chihchuan

Agent Shelston IP

Pub. Number AU-A-2008219238

PCT Pub. Number WO2008/102007

Priority 07102886.4 22.02.07 EP; PCT/ EP2007/058571 17.08.07 EP

Filing date 22 February 2008

Wipo publication date 28 August 2008

International Classifications

C07K 14/61 (2006.01) Peptides having more than 20 amino acids

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/54 (2006.01) Mutation or genetic engineering - Transferases (2)

Event Publications

6 August 2009 PCT application entered the National Phase

  PCT publication WO2008/102007 Priority application(s): WO2008/102007

17 December 2009 Amendment Made

  The nature of the amendment is: Amend the co-inventor from Zin, Xao to Zhao, Xin

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008219247-Implant for fracture care

2008219226-Indole derivatives